Takeda to Market Sucampo’s Constipation Drug
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 54 (Table of Contents)
Published: 4 Dec-2004
DOI: 10.3833/pdr.v2004.i54.753 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
Japan’s largest drug maker Takeda Pharmaceutical has formed an agreement with Sucampo Pharmaceuticals to market lubiprostone in US and Canada through its wholly owned subsidiary Takeda Pharmaceuticals North America...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS